v3.23.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 580,176 $ 632,138
Accounts receivable, net 48,987 138,624
Inventory 47,402 43,152
Prepaid expenses and other current assets 22,515 25,798
Government funding receivable 232 8,190
Total current assets 699,312 847,902
Property and equipment, net 141,619 52,694
Goodwill 326,459 283,668
Intangible assets, net 234,726 216,663
Deferred tax assets 769,586 765,799
Other assets 92,735 115,589
Total assets 2,264,437 2,282,315
Current liabilities:    
Accrued expenses and other current liabilities 50,344 53,371
Deferred revenue 2,459 3,088
Current portion of long-term debt 5,440 5,440
Current portion of finance lease liabilities 560 0
Total current liabilities 74,919 110,144
Long-term debt, less current portion 520,336 521,997
Finance lease liabilities, less current portion 32,236 0
Deferred tax liabilities 8,512 0
Other long-term liabilities 62,862 68,975
Total liabilities 1,366,799 1,377,072
Stockholders’ equity:    
Additional paid-in capital 119,903 137,898
Retained earnings 398,158 404,766
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc. 520,571 545,218
Non-controlling interest 377,067 360,025
Total stockholders’ equity 897,638 905,243
Total liabilities and stockholders’ equity 2,264,437 2,282,315
Nonrelated Party    
Current liabilities:    
Accounts payable 6,658 5,991
Related Party    
Current liabilities:    
Accounts payable 9,458 42,254
Payable to related parties pursuant to the Tax Receivable Agreement, less current portion 667,934 675,956
Class A Common Stock    
Stockholders’ equity:    
Common stock 1,319 1,317
Class B Common Stock    
Stockholders’ equity:    
Common stock $ 1,191 $ 1,237

Source

HTML PDF
ZIP